Clinical Trial: Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart Failure (NYHA Class III-IV)

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496372) titled 'Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart Failure (NYHA Class III-IV)' on March 16.

Brief Summary: The purpose of this clinical study is to evaluate the efficacy and safety of intramyocardial injection of human induced pluripotent stem cell-derived cardiomyocyte injection (HiCM-188) in patients with advanced heart failure (NYHA Class III-IV)

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Heart Failure

Intervention: BIOLOGICAL: HiCM-188 therapy

Intramyocardial Injection of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte I...